Status:
COMPLETED
Fentanyl Use for Sedation in Esophagogastroduodenoscopy
Lead Sponsor:
St. Joseph's Healthcare Hamilton
Collaborating Sponsors:
McMaster University
Conditions:
Endoscopy
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether conscious sedation with a narcotic and sedative (in combination) is as efficacious as a sedative alone for elective upper endoscopy to achieve optimal...
Detailed Description
Upper endoscopy is a valuable procedure that involves a camera advanced from the mouth into the intestines. It is a routine test and considered very safe. However, patients can experience discomfort f...
Eligibility Criteria
Inclusion
- outpatient elective upper endoscopy
- age 18-65
- able to give consent
Exclusion
- mental incompetency
- pregnancy
- weight \<55kg or 110 lbs
- emergent procedures,
- known hypersensitivity or allergy to fentanyl or midazolam
- chronic use of benzodiazepines or opioids
- patients known a priori to require therapeutic interventions in conjunction with their EGD
- patients to have major cardiorespiratory comorbidities, obstructive sleep apnea, liver cirrhosis, or renal failure
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
139 Patients enrolled
Trial Details
Trial ID
NCT01514695
Start Date
February 1 2012
End Date
December 1 2012
Last Update
January 30 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada, L8N4A6